Pancreatic Cancer Research

ResearcherHarbin Institute of TechnologyNo recent work listed

Xinyuan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8361-9631; OpenAlex author ID A5100663158. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.844648↗
  2. Pharmacometabolomics Identifies 3-Hydroxyadipic Acid, d-Galactose, Lysophosphatidylcholine (P-16:0), and Tetradecenoyl-l-Carnitine as Potential Predictive Indi… First author DOI 10.3389/fonc.2019.01524↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huanjie Yang · 2 shared papers, 2019–2022 · strength 0.27
  2. Kai Li · 1 shared paper, 2022 · strength 0.17
  3. Hui Li · 1 shared paper, 2019 · strength 0.09
  4. Dongyuan Wu · 1 shared paper, 2019 · strength 0.09
  5. Mei Dong · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.